Hiroshi Kunugi Selected Research

SRS-A

12/2017	Correlation of reduced social communicational and interactional skills with regional grey matter volumes in schizophrenia patients.
11/2014	Verification of the utility of the social responsiveness scale for adults in non-clinical and clinical adult populations in Japan.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hiroshi Kunugi Research Topics

Disease

87	Schizophrenia (Dementia Praecox) 01/2022 - 04/2002
37	Bipolar Disorder (Manic Depressive Psychosis) 05/2021 - 02/2003
34	Major Depressive Disorder (Major Depressive Disorders) 01/2022 - 09/2005
24	Mental Disorders (Mental Disorder) 01/2020 - 04/2007
13	Inflammation (Inflammations) 01/2022 - 01/2014
11	Depressive Disorder (Melancholia) 01/2022 - 08/2004
10	Alzheimer Disease (Alzheimer's Disease) 09/2020 - 11/2002
7	Mood Disorders (Mood Disorder) 05/2020 - 08/2004
6	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 01/2021 - 10/2014
6	Cognitive Dysfunction 05/2020 - 09/2006
5	Brain Diseases (Brain Disorder) 04/2021 - 01/2010
3	Obesity 01/2021 - 01/2020
3	Body Weight (Weight, Body) 12/2020 - 10/2012
3	Parkinson Disease (Parkinson's Disease) 01/2020 - 05/2010
3	Neurodegenerative Diseases (Neurodegenerative Disease) 12/2019 - 12/2004
3	Cushing Syndrome 10/2015 - 10/2010
3	Psychotic Disorders (Schizoaffective Disorder) 01/2014 - 08/2005
2	Wounds and Injuries (Trauma) 01/2022 - 01/2020
2	Neuroinflammatory Diseases 01/2022 - 06/2018
2	Metabolic Diseases (Metabolic Disease) 08/2021 - 01/2021
2	Cytokine Release Syndrome 04/2021 - 02/2021
2	COVID-19 02/2021 - 01/2021
2	Autistic Disorder (Autism) 10/2018 - 11/2002
2	Dementia (Dementias) 01/2017 - 01/2014
2	Neoplasms (Cancer) 01/2017 - 01/2014
2	Fetal Growth Retardation (Intrauterine Growth Retardation) 04/2014 - 05/2010
2	Treatment-Resistant Depressive Disorder 09/2013 - 01/2012
2	Mitochondrial Diseases (Mitochondrial Disease) 12/2004 - 10/2004
1	Trauma and Stressor Related Disorders 09/2022
1	Malnutrition (Nutritional Deficiencies) 04/2021

Drug/Important Bio-Agent (IBA)

21	Brain-Derived Neurotrophic Factor (BDNF)IBA 11/2021 - 08/2003
15	Proteins (Proteins, Gene)FDA Link 12/2021 - 11/2002
14	Biomarkers (Surrogate Marker)IBA 01/2022 - 10/2004
10	Antipsychotic Agents (Antipsychotics)IBA 01/2021 - 09/2006
8	GlucocorticoidsIBA 01/2014 - 03/2008
7	CytokinesIBA 01/2022 - 08/2011
7	Nerve Growth Factors (Neurotrophins)IBA 01/2022 - 04/2002
6	Biological ProductsIBA 09/2022 - 01/2014
6	Interleukin-6 (Interleukin 6)IBA 01/2022 - 11/2011
6	Dopamine (Intropin)FDA LinkGeneric 01/2021 - 08/2008
6	Glutamic Acid (Glutamate)FDA Link 01/2021 - 04/2008
5	Dexamethasone (Maxidex)FDA LinkGeneric 04/2021 - 10/2010
5	theanineIBA 10/2019 - 02/2012
5	Amino Acids FDA Link 01/2018 - 02/2011
5	NucleotidesIBA 05/2015 - 12/2004
5	Serotonin (5 Hydroxytryptamine)IBA 09/2014 - 07/2010
5	Messenger RNA (mRNA)IBA 06/2014 - 02/2003
5	LithiumIBA 02/2012 - 02/2006
5	DysbindinIBA 03/2010 - 11/2004
4	lysophosphatidic acidIBA 12/2021 - 01/2019
4	EnzymesIBA 12/2021 - 01/2014
4	LipidsIBA 04/2021 - 12/2011
4	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 06/2014 - 12/2011
4	N-Methylaspartate (NMDA)IBA 06/2014 - 12/2011
4	Mitochondrial DNA (mtDNA)IBA 03/2009 - 12/2004
3	KynurenineIBA 01/2022 - 09/2014
3	Tryptophan (L-Tryptophan)FDA Link 01/2022 - 09/2014
3	C-Reactive ProteinIBA 01/2022 - 11/2019
3	Propolis (Bee Bread)IBA 02/2021 - 01/2020
3	Amyloid (Amyloid Fibrils)IBA 09/2020 - 01/2017
3	royal jellyIBA 09/2020 - 01/2020
3	Sucrose (Saccharose)IBA 02/2020 - 10/2012
3	Corticotropin-Releasing HormoneIBA 01/2020 - 10/2010
3	Dopamine Agonists (Dopamine Agonist)IBA 01/2018 - 01/2012
3	Serine (L-Serine)FDA Link 01/2018 - 02/2011
3	Hydrocortisone (Cortisol)FDA LinkGeneric 01/2018 - 01/2011
3	Phencyclidine (Angel Dust)IBA 06/2014 - 12/2011
2	Volatile Fatty AcidsIBA 08/2021 - 01/2021
2	FlavonoidsIBA 02/2021 - 01/2014
2	NAD (NADH)IBA 01/2021 - 10/2004
2	Fatty Acids (Saturated Fatty Acids)IBA 01/2021 - 05/2020
2	Glucose (Dextrose)FDA LinkGeneric 12/2020 - 01/2017
2	Pharmaceutical PreparationsIBA 09/2020 - 01/2014
2	Neural Cell Adhesion Molecules (Neural Cell Adhesion Molecule)IBA 01/2020 - 01/2017
2	Antidepressive Agents (Antidepressants)IBA 01/2019 - 10/2010
2	Amphetamine (Amfetamine)FDA LinkGeneric 01/2018 - 05/2006
2	Oxytocin (Pitocin)FDA LinkGeneric 01/2018 - 08/2012
2	Chlorpromazine (Thorazine)FDA Link 01/2018 - 02/2012
2	SRS-AIBA 12/2017 - 11/2014
2	AnkyrinsIBA 11/2016 - 04/2014
2	fallyprideIBA 12/2015 - 04/2015
2	Methylphenidate (Ritalin)FDA LinkGeneric 12/2015 - 04/2015
2	Hormones (Hormone)IBA 10/2015 - 01/2014
2	EndocannabinoidsIBA 01/2015 - 05/2010
2	CannabinoidsIBA 01/2015 - 05/2010
2	CatecholaminesIBA 01/2014 - 12/2012
2	Metabotropic Glutamate Receptors (Metabotropic Glutamate Receptor)IBA 04/2008 - 04/2008
1	Docosahexaenoic AcidsIBA 12/2021
1	LysophospholipidsIBA 12/2021
1	caffeic acid phenethyl esterIBA 02/2021
1	Liposomes (Liposome)IBA 02/2021
1	Rutin (Rutoside)IBA 02/2021
1	Antiviral Agents (Antivirals)IBA 02/2021
1	naringinIBA 02/2021
1	artepillin CIBA 02/2021
1	remdesivirIBA 02/2021

Therapy/Procedure

2	Therapeutics 01/2022 - 12/2006
2	Apitherapy 09/2020 - 01/2020
2	Polypharmacy 12/2006 - 09/2006
1	Artificial Respiration (Mechanical Ventilation) 04/2021